Calumet, Inc.
NASDAQ:CLMTOil & Gas Exploration & Production
-$1.21 today
- Market cap
- $2.67B
- Beta
- 0.72
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$2.17
Volume 1.74M
Average 1.11M
CLMT Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Calumet, Inc.NASDAQ: CLMT
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $11.8M (cash outflow) rose 40.5% year over year, ahead of the +17.6% change in trailing-twelve-month capital expenditures. Sequentially, it fell 69.2% from the prior quarter. Over 3 fiscal years it compounded at -54.0% a year.
Context
- Capital expenditures amounted to 1.3% of revenue in FY2025, down 0.6 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +40.5% holds above the trailing-twelve-month pace of +17.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (52.3M) USD
- Year-over-year change
- +31.8%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (52.3M) | +31.8% |
| FY2024 | 2024-12-31 | (76.7M) | +71.8% |
| FY2023 | 2023-12-31 | (271.8M) | +49.3% |
| FY2022 | 2022-12-31 | (536.2M) | -546.8% |
| FY2021 | 2021-12-31 | (82.9M) | — |
Capital Expenditures vs competitors
How CLMT compares with its peers on the latest reported figures
- CLMT's LTM Sep 2026 capital expenditures of $76M is the 6th largest of the 11 companies compared; the peer median is $80.34M.
- Its year-over-year change of +17.6% is the 4th highest of 11, against a peer median of -5.5%.
- Capital expenditures amounts to 1.5% of revenue for CLMT, versus a peer median of 4.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $228M | -26.9% | -11.5% | 3.9% | |
| LTM Aug 2026 | $219.55M | -9.1% | -4.2% | 2.8% | |
| LTM Jun 2026 | $216M | -28.5% | +9.1% | 5.9% | |
| LTM Mar 2026 | $177.13M | +356.6% | -25.9% | 7.6% | |
| LTM Jun 2026 | $100.08M | +72.3% | +11.4% | 3.6% | |
| LTM Sep 2026 | $76M | +17.6% | -54.0% | 1.5% | |
| LTM Jun 2026 | $60.6M | +21.4% | +5.9% | 3.3% | |
| LTM Sep 2026 | $57.9M | -1.9% | -26.0% | 5.1% | |
| LTM Jun 2026 | $30.73M | -28.8% | +50.9% | 4.1% | |
| LTM Sep 2026 | $22.23M | -12.6% | +25.1% | 1.1% | |
| LTM Mar 2026 | $18.63M | +13.6% | +53.4% | 16.9% | |
| Peer median (excluding CLMT) | $80.34M | -5.5% | +7.5% | 4.0% | |
Competitors are the stored peer set for CLMT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (260.1M) | (169.8M) | 48.1M | (222M) | (33.8M) |
| Depreciation & Amortization | 107.7M | 98.3M | 146.8M | 149M | 148.8M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 50.7M | 0 | 14.7M | 14.6M | (4.5M) |
| Change in Working Capital | (45.1M) | (189.5M) | (25.1M) | 10.2M | (3.1M) |
| Accounts Receivables | (91.4M) | (14.1M) | (19.2M) | 8M | 47M |
| Inventory | (27M) | (190.5M) | 25.1M | 16.1M | 14.9M |
| Accounts Payables | 71M | 56.9M | (12.4M) | 1.7M | (52.2M) |
| Other Working Capital | 2.3M | (41.8M) | (18.6M) | (15.6M) | (12.8M) |
| Other Non-Cash Items | 102.8M | 361.6M | (199.4M) | 1.8M | 1.5M |
| Operating Cash Flow | (44M) | 100.6M | (14.9M) | (46.4M) | 108.9M |
| Capital Expenditures | (82.9M) | (536.2M) | (271.8M) | (76.7M) | (52.3M) |
| Acquisitions (Net) | 0 | 250.2M | 0 | 0 | 96.9M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (500K) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 100K | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (82.8M) | (286M) | (271.8M) | (76.7M) | 44.1M |
| Debt Repayment | 41.4M | (254.2M) | 248.7M | 97.7M | (86.8M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (4.4M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 97.9M | 357.3M | 17.5M | 56.6M | 93M |
| Financing Cash Flow | 139.3M | 98.7M | 266.2M | 154.3M | 6.2M |
| Effect of Forex Changes | 0 | 83.8M | 0 | 0 | 0 |
| Net Change in Cash | 12.5M | (2.9M) | (20.5M) | 31.2M | 159.2M |
| Free Cash Flow | (126.9M) | (435.6M) | (286.7M) | (123.1M) | 56.6M |
Calumet, Inc.
NASDAQ:CLMT
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.